Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Gemcitabine and carboplatin plus antibiotic (moxifloxacin)|DRUG: Gemcitabine combined with carboplatin plus placebo
Sponsor: Sun Yat-sen University